Whitehawk Therapeutics, Inc. (WHWK)
NASDAQ: WHWK · Real-Time Price · USD
2.840
+0.020 (0.71%)
At close: Feb 11, 2026, 4:00 PM EST
2.830
-0.010 (-0.35%)
After-hours: Feb 11, 2026, 4:00 PM EST
Whitehawk Therapeutics Market Cap
Whitehawk Therapeutics has a market cap or net worth of $133.84 million as of February 11, 2026. Its market cap has increased by 81.01% in one year.
Market Cap
133.84M
Enterprise Value
-28.75M
1-Year Change
81.01%
Ranking
Category
Stock Price
$2.84
Market Cap Chart
Since August 27, 2021, Whitehawk Therapeutics's market cap has decreased from $540.80M to $133.84M, a decrease of -75.25%. That is a compound annual growth rate of -26.88%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 10, 2026 | 132.43M | 16.12% |
| Dec 31, 2025 | 114.05M | 46.67% |
| Dec 31, 2024 | 77.76M | 56.96% |
| Dec 29, 2023 | 49.54M | -84.17% |
| Dec 30, 2022 | 312.99M | -37.97% |
| Dec 31, 2021 | 504.59M | -6.70% |
| Aug 27, 2021 | 540.80M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Vaxart | 142.63M |
| Cibus | 140.52M |
| Connect Biopharma Holdings | 138.08M |
| Spero Therapeutics | 136.34M |
| Oramed Pharmaceuticals | 135.73M |
| Sutro Biopharma | 132.22M |
| Fate Therapeutics | 131.50M |
| Black Diamond Therapeutics | 128.48M |